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Available online 13 October 2016Objective: The objective of this study was to evaluate the efﬁcacy of the educational program FAMOSES (modular
service package epilepsy for families) for parents of children with epilepsy.
Method: Parents of children with epilepsy from Germany and Austria were included in a controlled prospective
multicenter study using a pre–post design. Participants of the FAMOSES program (FAMOSES group, n = 148)
completed a standardized questionnaire immediately before the program and six months later. The matched
control group of parents not participating in the program (n = 74, matching ratio 2:1) also answered the
questionnaire twice, at an interval of six months. The questionnaire comprised epilepsy-speciﬁc outcome
measures (e.g., knowledge, coping, fears) and disease-related variables (e.g., seizure frequency). The generalized
estimation equation approach was used for statistical analysis. In addition, parents' satisfaction with the
FAMOSES program was assessed six months after participation.
Results: Parents of the FAMOSES group signiﬁcantly improved in epilepsy-speciﬁc knowledge (group × time
interaction: p b .001), coping (p b .01), epilepsy-related fears (p b .05), and in speaking about epilepsy with
their child (p b .05) comparedwith the control group. No effects were found on disease-related variables. Nearly
all of the participants rated the FAMOSES parents' program as “very good” (71%) or “good” (27%).
Conclusion: The efﬁcacy of the FAMOSES parents' program was conﬁrmed. The results indicate that imparting
knowledge and the interactive approach help parents in coping with their child's epilepsy and reduce
epilepsy-related fears.Bielefeld University, Postfach
Hagemann).
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Epilepsy has a considerable impact not only on affected children but
also on their families [1]. Besides having to cope with the unpredictable
occurrence of seizures, childrenwith epilepsy (CWE) show an increased
risk of emotional and behavioral problems [2–4]. For parents, having a
child with epilepsy is associated with stress, symptoms of depression
and anxiety, and impaired quality of life, especially when the child has
comorbid neurological deﬁcits [5–7]. At the same time, parents' concern
for their childwith chronic illness often results in overprotective and re-
strictive parenting behavior,whichmay interferewith the development
of their child's autonomy [8,9].
Thus, it is not surprising that, evenwhen the child's epilepsy is well-
controlled, the parents' need for psychosocial care and information is10
license (still high two years after diagnosis [10]. Although it was shown that a
higher level of knowledge is associated with fewer restrictions in family
activities, less parental worries, and less perceived stigmatization
and isolation [11], knowledge gaps are common in parents of CWE
[12–16]. Parents of CWE are afraid of misinforming their child when
talking about its disorder [17] and often feel apprehensive about letting
their child participate in physical activities or school trips [14,18], so
that improving parents' knowledge is an important means to help
them cope with their child's epilepsy. Moreover, a higher parental
need for psychosocial care is associated with less encouragement of
their child's autonomy [10]. Therefore, acomprehensive epilepsy care
plan that addresses not only medical aspects but also psychosocial
needs of parents of CWE is recommended [19,20]. Educational pro-
grams for CWE and their parents are an important component in this
context because they provide information and also cover coping strate-
gies and emotional aspects of living with epilepsy [21].
The educational program FAMOSES (modulares Schulungsprogramm
Epilepsie für Familien, modular service package epilepsy for families)http://creativecommons.org/licenses/by-nc-nd/4.0/).
144 A. Hagemann et al. / Epilepsy & Behavior 64 (2016) 143–151[22] is provided in outpatient settings in Germany, Austria, and
Switzerland. It consists of a program for CWE aged 7–12 years and a
matched parents' program. Participants of the children's program go
on a virtual “cruise” with islands representing the modules
(e.g., “treasure island” for the diagnostic process) and discover aspects
of living with epilepsy playfully. The parents' program covers the
same topics (basic knowledge, diagnostic procedures, therapeutic op-
tions, and informing others about epilepsy) but also includes additional
modules on prognosis, development, and everyday life with CWE (e.g.,
reducing unnecessary restrictions). The course is interactive, and differ-
ent techniques (e.g., mindmaps, group discussions) are used to encour-
age parents to express emotions and to exchange experiences. More
detailed information on the program is given elsewhere [22]. The two
programs are independent insofar as parents can attend FAMOSES
even if their child does not participate in the children's program
(e.g., if the child is too young). Thus, FAMOSES is the only educational
program for parents of very young or disabled CWE in Germany. All
FAMOSES trainers have professional experience in working with CWE
and are qualiﬁed as trainers. Besides improving participants' knowl-
edge, FAMOSES aims at the reﬂection of attitudes and the development
of strategies to facilitate coping and disease management.
During the development of FAMOSES, a pilot study was performed to
evaluate the feasibility of the two programs which yielded some promis-
ing results [23,24]. Yet the sample sizes were relatively small, partly be-
cause of high dropout rates, and the follow-up period of three months
was relatively short. Most of the questionnaires used were newly devel-
oped and could not be pretested, leading to ceiling effects and low reli-
ability for some scales, thus limiting the validity of the results.
Meanwhile, the FAMOSES manual was revised, and structured
“train-the-trainer” courses have been introduced as a qualiﬁcation
criterion. For these reasons, the aimof the current studywas to investigate
the efﬁcacy of the FAMOSES parents' programwith a modiﬁed research
design, a larger sample size, a longer follow-up period, and improved
instruments.
2. Methods
This report follows the CONSORT (Consolidated Standards of
Reporting Trials) guidelines for nonpharmacologic treatments [25,26].
2.1. Study design and participants
Weperformed a prospective, open,multicenter study using a pretest–
posttest-control group design to evaluate the efﬁcacy of the FAMOSES
parents' program. Two groups of parents of CWE were asked to answer
questionnaires twice at an interval of six months (baseline and follow-
up). The FAMOSES group participated in the FAMOSES parents' program
directly after the baseline measurement, while the control group did not
take part in FAMOSES during the study period.
A random allocation of parents to the study groups was not feasible
for the following reasons: For one thing, we wanted to give all parents
who were interested in FAMOSES the opportunity to participate
(as soon as possible). Moreover, most cooperating epilepsy centers
were not able to offer the program more than once a year whereas a
randomized design with a waiting list control group would require a
second FAMOSES course after six months. These centers would not
have been able to participate in a randomized study, limiting both
sample size and generalizability of the results. Therefore, the control
group was recruited independently from the FAMOSES group (see
Section 3.1). However, participants were matched based on demo-
graphic and disease-related variables at baseline to achieve structural
equality of the two groups without randomization.
The participants were parents whose childrenwere treated in one of
the 19 cooperating epilepsy centers in Germany and Austria. Inclusion
criteria comprised having a child with a veriﬁed epilepsy diagnosis.
Additionally, the child was supposed to have had at least one seizurein the previous year (active epilepsy). During the recruitment phase, it
turned out that some participants of the FAMOSES parents' program
had children with longer seizure-free periods. Since these children
were still treated by a neurologist/neuropediatrician and were on anti-
convulsant medication, the latter inclusion criterion was relaxed.
Parents were excluded from the study if they had an insufﬁcient knowl-
edge of the German language or if their child had solely nonepileptic
seizures. Only one baseline and one follow-up questionnaire per family
were included in the statistical analysis.
Parents ﬁlled in the questionnaires anonymously and returned them
to the Society for Epilepsy Research in a sealed envelope. Written
informed consent was obtained from all parents, and the study was
approved by the ethics committee of the Department of Psychology at
Bielefeld University.
2.2. Intervention
Each FAMOSES course was conducted by two certiﬁed FAMOSES
trainers (one of them being a pediatrician) and carried out according
to the trainer's manual which provides information on course contents,
materials and didactic techniques, and also allows some adjustment of
contents based on the participating parents' needs (e.g., provided that
all children are at school age, topics about kindergarten are skipped).
All courses were delivered on weekends (2–3 days) with a total dura-
tion of 14 h and group sizes of 6–13 parents.
2.3. Objectives and hypotheses
Three primary outcomes that cover different aims of the FAMOSES
parents' program were deﬁned. We hypothesized that, compared with
the control group, the participation in the FAMOSES parents' program
would improve
• epilepsy-speciﬁc knowledge,
• parental coping with epilepsy, and
• encouragement of the child's autonomy.
Furthermore, we expected an improvement in the following
secondary outcomes: epilepsy-related fears, information seeking and
sharing of information, seizure management, speaking about epilepsy
with the affected child, and impact of epilepsy on the family.
The effects of the FAMOSES parents' program on different disease-
related variables (e.g., seizure frequency) were explored, and the
satisfaction of parents with the FAMOSES program was assessed six
months after participation.
2.4. Outcome measures and questionnaires
Epilepsy-speciﬁc questionnaires were developed based on the
experience from the pilot study [23,24]. We selected items with good
psychometric properties for our outcome measures and added some
new items. To assess the impact of the child's epilepsy on the family, a
short form of the German version of the Impact on Family Scale (IOFS)
[27] was used. Except for the questionnaire on satisfaction with the
FAMOSES program, all scales were presented both at baseline and at
follow-up. Psychometric information and sample items are given in
Table 1.
Additionally, parents were asked for age, marital status, education
level, and employment status. Demographic and disease-related data
of their children were also assessed (e.g., age, gender, type of schooling,
development status, age of onset of epilepsy, and comorbidities).
2.4.1. Primary outcome measures
Epilepsy-speciﬁc knowledge. The scale developed to assess parents'
knowledge about epilepsy consists of statements which the parents
were asked to judge as true or false. A “don't know” category was
Table 1
Outcome measures.
Scales and questionnaires (sample item) No of
items
Answer categories Cronbach's
alphaa
ICCb Explained
variance (EFA)c
Epilepsy-speciﬁc knowledge (“Epileptic seizures always cause loss of brain cells.”) 18 “True”, “False”, “Don't know” .752 .834 26.88%
Coping with epilepsy (“I feel strong enough to cope with my child's epilepsy.”) 7 4-point Likert (“strongly disagree”
to “strongly agree”)
.714 .506 33.92%
Encouragement of the child's autonomy (“I encourage my child to stand up to its epilepsy.”) 7 4-point Likert (“strongly disagree”
to “strongly agree”)
.777 .832 44.76%
Epilepsy-related fears (2 subscalesd): 53.58%
Fears about short-term consequences of the child's epilepsy (“I am afraid that my
child can have a seizure at any time.”)
8 5-point Likert (“not at all” to
“very much”)
.891 .765
Fears about the future development of the child and its epilepsy (“I am afraid that
my child's seizures will deteriorate.”)
9 5-point Likert (“not at all” to
“very much”)
.913 .801
Information seeking and sharing of information (“I seek contact to other parents whose
child has epilepsy as well.”)
5 7-point Likert (“never” to “always”) .737 .687 44.38%
Seizure management (“I move objects out of reach on which the child could hurt itself.”) 5 7-point Likert (“never” to “always”) .720 .551 52.61%
Speaking about epilepsy with the affected child (“I speak to my child about the seizures.”) 3 4-point Likert (“strongly disagree”
to “strongly agree”)
.820 .799 69.39%
Impact on Family Scale (IOFS) 11-item short form (“We see family and friends less often
because of the illness.”)
11 4-point Likert (“strongly disagree”
to “strongly agree”)
.936 .862 66.95%
a Cronbach's αwas computed for all parents included at baseline with complete data on the speciﬁc scale (n= 245–288).
b ICC= intraclass correlation coefﬁcient (for absolute agreement, single measures) computed for the participants of the control group at baseline and follow-up (n= 61–85).
c EFA = exploratory factor analysis. For all scales except epilepsy-related fears, EFAs led to one-factor solutions.
d Based on the exploratory factor analysis (correlation between factors r= .651).
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analyzed.
Coping with epilepsy includes active dealing with the child's
condition as well as the absence of feelings of resignation and
hopelessness. An exploratory factor analysis (EFA) showed that
both aspects belong to a single dimension. All items were taken
from the scale “adaptation to epilepsy” that was used in the pilot
study [23,24].
Encouragement of the child's autonomy: Parents were asked how
far they encourage their child to be autonomous and to cope with its
disorder actively, in contrast to an (over)protective behavior of the
parents.2.4.2. Secondary outcome measures
Epilepsy-related fears. The scale used in the pilot study [23,24] was
divided into two subscales based on the results of an EFA: Fears about
short-term consequences of the child's epilepsy (e.g., constant fear of
potential seizures) and fears about the future development of the
child and its epilepsy (e.g., negative long-term effects of anticonvulsant
medication).
Information seeking and sharing of information: Parents were
asked to what extent they talk with teachers or friends about their
child's condition and how far they seek further information on
epilepsy.
Seizure management refers to adequate emergency management of
the parents during their child's seizure. Parents rated how often they
show different kinds of possible reactions.
Speaking about epilepsy with the affected child includes conversations
about seizures and medication.
Impact on Family Scale. This instrument assesses the impact that a
child with chronic illness or disability has on the family. In this study,
an 11-item short form of the German version that was validated for
parents of CWE was used [27–30].
All scale scores were transformed into values between 0 and 100
except for the IOFS, for which the original value range (1–4) was
retained. Higher scores indicate a higher manifestation of the
respective construct, i.e., an increase in scores reﬂects a positive
development for all scales except epilepsy-related fears and IOFS
where higher scores represent more fears and more (negative) impact,
respectively.2.4.3. Disease-related variables
Seizure frequency was assessed with six categories (Table 2). Toler-
ability and efﬁcacy of anticonvulsant drug therapy were rated by the
parents using a scale with four categories (Table S2). We assessed the
number of days the child was absent at school/kindergarten because
of seizures in the last three months as well as consultation rates due
to seizures.
2.4.4. Satisfaction with the FAMOSES parents' program
Participants of the FAMOSES group evaluated the material used
during the course, their expectations, their acquisition of new knowl-
edge and skills, and whether they would recommend the program to
other parents.
2.5. Sample size calculation
The required sample size was determined a priori based on the
following assumptions: As the family-wise error rate for testing the
three primary outcome measures should not exceed α= .05, we used
a Bonferroni-corrected signiﬁcance level of α′ = α / n (tests) = .05 /
3 = .017. The expected correlation of r = .70 between baseline and
follow-up measurement was derived from the pilot study [23,24], and
the power was set at 1− β= .80. To detect a small interaction effect
(f = 0.1) [31] in a 2 × 2 (FAMOSES vs. control group × baseline vs.
follow-up) repeated measures analysis of variance (ANOVA) based
on these assumptions, the required sample size was calculated to be
n = 80 per group (using G*Power 3.1.3) [32]. Expecting a dropout
rate of 20%, we planned to include 200 parents in the study (n = 100
per group).
2.6. Statistical methods
Although the overall percentage of missing values for the outcome
measures was low (3.0%), missing item values were imputed using the
fully conditional speciﬁcation method [33,34]. Five imputed datasets
were created, and the parameters and standard errors of the following
analyses were combined to an overall estimate using Rubin's rules [35].
Generalized estimation equations (GEE) [36,37] were used to
analyze the effects of the FAMOSES parents' program. In contrast to
repeated measures ANOVA, time-varying covariates can be included in
Table 2
Demographic characteristics of matched parents' groups and demographic and clinical characteristics of their children with epilepsy.
FAMOSES group
n = 148
Control group
n = 74
p-Valuea
Demographic characteristics of the parents
Respondent, n (%)
Mother/foster mother/grandmother 122 (82.4%) 65 (87.8%) .264
Father 13 (8.8%) 7 (9.5%)
Mother and father 13 (8.8%) 2 (2.7%)
Age (years), mean ± SD (range) 39.07 ± 6.64 (22–63) 38.69 ± 7.14 (21–62) .697
Marital status, n (%)
Living with spouse/partner 123 (83.1%) 63 (85.1%) .874
Single parent 25 (16.9%) 11 (14.9%)
Education, n (%)
Without school leaving certiﬁcate 1 (0.7%) 2 (2.7%) .337
Secondary general school (9 or 10 years) 26 (17.6%) 9 (12.2%)
Intermediate school leaving certiﬁcate (10 years) 65 (43.9%) 38 (51.4%)
Higher education entrance qualiﬁcation 56 (37.8%) 25 (33.8%)
Employment, n (%)
Employed 100 (67.6%) 47 (63.5%) .488
Unemployed 3 (2.0%) 2 (2.7%)
Housewife/man 34 (23.0%) 15 (20.3%)
No information/otherb 11 (7.4%) 10 (13.5%)
Demographic characteristics of parents' children with epilepsy
Gender, n (%, female) 70 (47.3%) 33 (44.6%) .776
Age (years), mean ± SD (range) 8.73 ± 4.19 (0.42–20.92) 8.72 ± 4.54 (0.75–17.75) .991
Educational institution, n (%)
Kindergarten 30 (20.3%) 22 (29.7%) .287
School 97 (65.5%) 42 (56.8%)
Other 8 (5.4%) 6 (8.1%)
None 13 (8.8%) 4 (5.4%)
Clinical characteristics of parents' children with epilepsy
Age at onset of epilepsy (years), mean ± SD (range) 4.60 ± 3.81 (0.00–15.67) 4.19 ± 3.54 (0.00–13.75) .442
Treatment with anticonvulsant medication, n (%, yes) 145 (98.0%) 72 (97.3%) N .999
Identity card for severely disabled persons, n (%) 65 (43.9%) 38 (51.4%) .320
Comorbidity, n (%, yes) 64 (43.2%) 38 (51.4%) .318
Baseline seizure frequency (in the past six months), n (%) n = 146 n = 74
No seizures 29 (19.9%) 12 (16.2%) .209
1–2 seizures 23 (15.8%) 14 (18.9%)
3–5 seizures 37 (25.3%) 9 (12.2%)
1–2 seizures per month 13 (8.9%) 9 (12.2%)
≥1 seizure per week 13 (8.9%) 9 (12.2%)
≥1 seizure per day 31 (21.2%) 21 (28.4%)
a t-Test for independent groups (metric variables) or Fisher's exact test (categorical variables).
b Other: self-employed, vocational training, retired, student, parental leave, marginal employment.
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frequency was not only correlated with several outcome measures but
also changed over time. We modeled the main effects of group
(FAMOSES vs. control group) and time (baseline vs. follow-up) and
their interaction. The GEE parameters were tested for signiﬁcance
usingWald tests, and estimatedmarginal means were computed to ob-
tain statistics adjusted for seizure frequency. Effect sizes for the interac-
tion effects were calculated as dppc2 which was proposed and tested by
Morris [38] for pretest–posttest-control group designs.
Except for the primary outcome parameters (adjusted α′ = .017),
the criterion for statistical signiﬁcance was set atα= .05. For all analy-
ses, two-sided p-values are reported. For statistical and psychometric
analyses, we used IBM SPSS Statistics for Windows (version 23.0).
3. Results
3.1. Participant ﬂow and sample characteristics
During the planned 14-month recruitment period (October 2011–
November 2012), 194 participants from 27 FAMOSES courses were
included in the FAMOSES group (Fig. 1). Since parents eligible for the
control group were consecutively asked for study participation during
their regular visits in the cooperating epilepsy centers, the recruitmentof the planned sample size for the control group had to be extended
(21 months, December 2011–August 2013), resulting in a baseline
sample size of 104 control group parents.
Most of the parents included at baseline returned a study question-
naire at follow-up after six months and were principally eligible for
analysis (FAMOSES group: 158/194, control group: 86/104; Fig. 1).
The two groups were comparable with respect to demographic
variables of parents and their children (data not shown). However,
children of control group participants had a signiﬁcantly higher seizure
frequency than those of the FAMOSES group (p = .025, Fisher's exact
test), thus stressing the importance of matching in order to achieve
comparability of the groups.
Since the FAMOSES group was considerably larger than the control
group, the groups were matched in a 2:1 ratio. Primary matching
variableswere parents' ratings of their child's impairment due to epilepsy
(very strong/strong, moderate, slight/none) and parental education
(Table 2). Both were selected because of their correlations with the out-
come criteria. Additionally, the child's seizure frequency and age were
taken into account.
Thematching procedure resulted in 74 triples of comparable parents
so that the matched sample for the analysis of the effects of the
FAMOSES parents' program consisted of 148 parents in the FAMOSES
group and 74 parents in the control group (Fig. 1). After matching, the
Fig. 1. Participant ﬂow. Abbreviation: CWE = child with epilepsy.
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or clinical characteristics of the participants or their children with
epilepsy, which are summarized in Table 2.3.2. Effects of the FAMOSES parents' program on primary outcome criteria
3.2.1. Epilepsy-speciﬁc knowledge
Generalized estimation equation analysis revealed a signiﬁcant
group × time interaction for parents' knowledge on epilepsy
(p b .001) with a large effect size of dppc2 = .795 (Table 3). This means
that, six months after participation in the educational program, the
increase in knowledge in the FAMOSES group was signiﬁcantly higher
compared with the control group in which the level of knowledge
did not change signiﬁcantly in the study period (p = .819; Fig. 2A).
Baseline knowledge did not differ between the groups (main effect
group: p= .500).3.2.2. Coping with epilepsy
Since parents' coping with their child's epilepsy was correlated
with the child's seizure frequency, this variable was included in the
GEE analysis as a time-varying covariate. Results indicated a signiﬁcant
group × time interaction (p = .003) with a small-to-medium effect
size (dppc2 = .389; Table 3). The improvement in coping was signiﬁ-
cantly higher in the FAMOSES group compared with the control
group in which the level of coping even decreased slightly (although
only marginally signiﬁcant, p = .086; Table 3; Fig. 2B). Baseline level
of coping did not differ between the groups (main effect group:
p = .155).3.2.3. Encouragement of the child's autonomy
Generalized estimation equation analysis (adjusted for seizure
frequency) did not show an effect of FAMOSES on parents' encourage-
ment of the child's autonomy (group × time interaction: p = .523).
Baseline levels of the groups were comparable, and the scores did
not change signiﬁcantly over time (main effects: p = .997 for group,
p= .767 for time; Table 3; Fig. 2C).
3.3. Effects of the FAMOSES parents' programon secondary outcome criteria
3.3.1. Epilepsy-related fears
Six months after participation in the FAMOSES program, parents of
the FAMOSES group reported less fears about short-term consequences
of their child's epilepsy whereas the control group's level of fears
remained stable (GEE, group × time interaction: p = .030, dppc2 =
.239; Table 3). The effect of FAMOSES on parents' fears about the future
development of the child and its epilepsywas slightlymore pronounced
with an effect size of dppc2 = .313 (GEE adjusted for seizure frequency,
group × time interaction: p = .003; Table 3). Again, a decrease in the
level of fears was observed after participation in the FAMOSES course,
while the control group's fears remained unchanged (Fig. 2D).
3.3.2. Speaking about epilepsy with the affected child
Generalized estimation equation analysis (adjusted for seizure
frequency) revealed a signiﬁcant group × time interaction (p = .033)
with an effect size of dppc2 = .236, indicating that the increase in
speaking about epilepsywith the affected child was signiﬁcantly higher
compared with the control group. Neither the change in the control
group nor the baseline difference between the groups was signiﬁcant
(p= .524 and p= .173, resp.).
Table 3
Outcome scores (estimated marginal mean ± standard error [SE]) at baseline and at follow-up after six months.
Control group
n = 74
FAMOSES group
n = 148
GEE analysisa
B (SE), p-value
Effect size
(interaction)
Baseline Follow-up Baseline Follow-up Groupb Timec Group × timed dppc2e
Primary outcome measures
Epilepsy-speciﬁc knowledge 48.36 ± 2.42 47.99 ± 2.28 46.40 ± 1.61 61.92 ± 1.37 −1.97 (2.92)
p = .500
−0.38 (1.64)
p = .819
15.90 (2.20)
p b .001
0.795
Coping with epilepsyf 67.45 ± 2.16 63.59 ± 2.04 63.68 ± 1.53 67.06 ± 1.44 −3.77 (2.65)
p = .155
−3.86 (2.24)
p = .086
7.23 (2.45)
p = .003
0.389
Encouragement of the child's autonomyf 58.42 ± 2.44 57.84 ± 2.66 58.43 ± 1.76 59.26 ± 1.85 0.01 (3.05)
p = .997
−0.58 (1.94)
p = .767
1.41 (2.20)
p = .523
0.066
Secondary outcome measures
Epilepsy-related fears
Fears about short-term consequences 41.52 ± 3.10 40.81 ± 2.77 40.97 ± 1.90 34.43 ± 1.75 −0.55 (3.64)
p = .879
−0.71 (2.19)
p = .746
−5.83 (2.68)
p = .030
0.239
Fears about the future developmentf 57.14 ± 2.82 59.60 ± 2.53 55.54 ± 1.92 50.62 ± 1.95 −1.60 (3.41)
p = .640
2.46 (1.89)
p = .193
−7.39 (2.34)
p = .002
0.313
Information seeking and sharing of
information
60.17 ± 2.25 55.14 ± 2.20 60.47 ± 1.51 58.57 ± 1.35 0.30 (2.70)
p = .912
−5.03 (1.87)
p = .007
3.13 (2.31)
p = .176
0.167
Seizure managementf 73.37 ± 2.73 76.28 ± 2.54 68.78 ± 2.30 72.39 ± 2.02 −4.58 (3.47)
p = .186
2.91 (2.73)
p = .287
0.69 (3.17)
p = .827
0.026
Speaking about epilepsy with the
affected child
57.24 ± 3.80 53.00 ± 3.97 54.28 ± 2.82 57.99 ± 2.51 −2.96 (4.64)
p = .524
−4.23 (3.09)
p = .173
7.94 (3.71)
p = .033
0.236
IOFS 11-item short formf 2.34 ± 0.09 2.29 ± 0.09 2.30 ± 0.06 2.35 ± 0.06 −0.04 (0.11)
p = .694
−0.05 (0.05)
p = .371
0.10 (0.07)
p = .126
−0.136
An increase in scores reﬂects a positive development for all scales except epilepsy-related fears and IOFSwhere higher scores representmore fears ormore (negative) impact, respectively.
a For the generalized estimation equations (GEE), parameters B and the corresponding standard errors (SE) are given together with p-values of Wald tests. (p b .05 in boldface)
b The parameter “group” is the difference of estimated marginal means between the groups at baseline (e.g., for knowledge: 46.396− 48.363 =−1.967).
c The parameter “time” is the change in estimated marginal mean from baseline to follow-up in the control group (e.g., for knowledge: 47.988− 48.363 =−0.375).
d The parameter “group × time” is the group difference in mean change over time (e.g., for knowledge: [61.922− 46.396]− [47.988− 48.363] = 15.901).
e dppc2 [38] standardizes the group difference in mean change using the pooled standard deviation at baseline.
f Estimated marginal means adjusted for the child's seizure frequency (included in GEE analysis as time-varying covariate). For all other scales, no correlations with seizure frequency
were found, or seizure frequency was not a signiﬁcant covariate in GEE analyses.
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FAMOSES parents' program (group × time interactions: all p N .10;
Table 3). The amount of information seeking and sharing of information
decreased in both groups, indicated by a signiﬁcant main effect of time
in the GEE analysis (p= .007; Table 3).
3.4. Effects of the FAMOSES parents' program on disease-related variables
Both in the FAMOSES and in the control group, children's seizure
frequency signiﬁcantly decreased from baseline to follow-up (main
effect time: p b .001, GEE; Table S1), whereas the group × time interac-
tion was not signiﬁcant (p= .756, GEE).
In line with this, parents reported an increase in the efﬁcacy of their
children's anticonvulsant drug therapy and a reduction of absenteeism
at school or kindergarten due to seizures, which was irrespective of
their group (main effect time: both p b .05, group × time interaction:
bothp N .05, GEE; Table S2). Analyses of consultation rates and tolerability
of anticonvulsant drug therapy did not show signiﬁcant effects of group
or time (p N .05 for main effects and interaction, GEE; Table S2).
3.5. Subgroup analyses and analysis of center effects
3.5.1. Children with severe chronic epilepsy
According to the guidelines of the German health insurances, not all
participants' children could be classiﬁed as suffering from a “severe
chronic condition”1 [39]. For this reason, all analyses were repeated
using only those parents whose children met the guideline criteria,1 These guidelines (“Chroniker-Richtlinie”) specify criteria for the deﬁnition of severe
chronic conditions according to theGerman Social Code, Book Five (SGB V, §62). Amedical
condition is chronic if it is treated by a physician for at least one year (at least once in every
quarter of a year) and a) the patient has a need for long-term care (care level 2 or 3,
GermanSocial CodeXI, Chapter 2) and/or b) the patient is severelydisabled (degree of dis-
ability of at least 60 according to theGerman law) and/or c) continuousmedical treatment
(e.g. drug therapy) is necessary.based on the information available from the study questionnaires
(FAMOSES group: n = 109, control group: n = 63). The results were
comparable with those of the complete sample in terms of signiﬁcant
effects and effect sizes (Table S3).
3.5.2. Exclusion of parents of children without seizures in the last year
In contrast to the initially formulated inclusion criteria, parents of
children without seizures in the last year participated in the study and
were not excluded from themain analyses. In the sense of a per protocol
analysis, the analyses for all outcome measures were repeated only for
parents of children with active epilepsy (as deﬁned in the inclusion
criteria; FAMOSES group: n= 131, control group: n= 67). Again, the
results did not differ considerably compared with those of the main
analyses (Table S4).
3.5.3. Center effects
A comparison of the effects of the FAMOSES parents' program
between the cooperating epilepsy centers did not indicate differences
in efﬁcacy (data not shown).
3.6. Satisfaction with the FAMOSES parents' program
For the evaluation of the educational program by the participating
parents, all questionnaires returned at follow-up were included
(n=169). Six months after participation, the parents' answers showed
a high degree of satisfaction with FAMOSES (Table 4).
4. Discussion
4.1. Methodological aspects
Our aim was to evaluate the efﬁcacy of the FAMOSES parents' pro-
gram in the context of its regular implementation in various epilepsy
centers in a methodologically sound study. Therefore, we used the
Fig. 2. Effects of FAMOSES parents' program on the three primary outcome measures (A–C, increase in scores = positive development) and on the parents' fears about the future
development of the child and its epilepsy (D, decrease in scores = positive development). Data are expressed as estimated marginal means ± standard error (adjusted for seizure
frequency as covariate for all scales except epilepsy-speciﬁc knowledge). p-Values for the group × time interaction are taken from the GEE analyses.
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ways to ensure validity of the results:
We increased the number of study participants. A priori sample size
calculations were executed, and the required number of parents was
reached for the control group and exceeded for the FAMOSES group.
The larger number of FAMOSES participants in the study is due to the
fact that the number of FAMOSES courseswithin the recruitment period
was larger than expected based on prior experience [23]. Both the
dropout rate and the number of excluded questionnaires were low
and within the expected range of 20%.
Moreover, the length of the follow-up period was extended from
three to six months to give FAMOSES participants the opportunity
to apply what they had learned during the course in everyday life.
Outcome measures were developed based on the item pool of the
pilot study, leading to internally consistent and reliable scales without
bottom or ceiling effects.
In addition to that, we used amatching procedure. Although this led
to the exclusion of some participants who could not be matched, it
ensured structural equality of the two matched groups with respect to
baseline variables. To further improve internal validity, data wereTable 4
Parents' satisfaction with the FAMOSES program.
Completely Rath
Expectations have been fulﬁlled 64.5% 29.0
Recommendation to other parents 86.9% 11.9
Very much Muc
New skills, new knowledge acquired 38.7% 39.3
FAMOSES helped in everyday management 26.2% 38.7
Feeling safer with seizure management 23.7% 39.1
Very good Goo
Evaluation of FAMOSES material 66.1% 30.4
Rating of FAMOSES program as a whole 71.4% 27.4analyzed using the GEE approach allowing us to account for changes
in the children's seizure frequency.
4.2. Efﬁcacy of the FAMOSES parents' program
Imparting knowledge is one of the primary aims of psycho-
educational programs [21,40], taking into account the need for informa-
tion that many parents of CWE have [10,19]. In line with previous
studies evaluating psychoeducational programs for families of CWE or
adult patients with epilepsy [21,40,41], the FAMOSES parents' program
successfully improved participants' knowledge about epilepsy.
Aside from providing information, FAMOSES trainers encourage
participants to develop strategies to cope with their child's disorder in
everyday life [23], and the interactive course setting gives various
opportunities to express and discuss attitudes and opinions as well as
fears. In accordance with these aims, our study has shown that the
FAMOSES parents' program was successful in improving parental
coping and in reducing epilepsy-related fears. The FAMOSES parents'
program further emphasizes the importance of understanding the
child's situation so that parents can help their child to cope with itser yes Partially Rather not Not at all
% 5.3% 0.0% 0.0%
% 1.2% 0.0% 0.0%
h Somewhat Little Not at all
% 18.5% 3.6% 0.0%
% 29.2% 4.8% 1.2%
% 28.4% 6.5% 2.4%
d Fair Poor Very poor
% 3.6% 0.0% 0.0%
% 1.2% 0.0% 0.0%
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the affected child is an important ﬁnding.
Parents' encouragement of the child's autonomy did not change
after participation in the FAMOSES parents' program. This is possibly
due to the fact that many participants' children were relatively young
and/or disabled. Questions about their autonomymay not be appropri-
ate because of their ongoing dependence on their parents.
Participation in the FAMOSES course did not improve parents'
seizuremanagement, but the scores on this scalewere already relatively
high at baseline, indicatingmainly adequate reactions of parents to their
children's seizures. Additionally, it has to be kept in mind that the
appropriate reaction depends on the seizure type.
We did not ﬁnd effects of the FAMOSES parents' programondisease-
related variables. In line with the results of the pilot study [23] and of
FLIP&FLAP [42], the only other evaluated psychoeducational program
for families of CWE in Germany, the change in children's seizure
frequency did not differ between treatment and control groups.
However, seizure frequency signiﬁcantly decreased in both groups,
demonstrating the efﬁcacy of the medical treatment that all partici-
pants' children received in the cooperating epilepsy centers.
4.3. Satisfaction with the FAMOSES parents' program
Since the educational programFAMOSESwas implemented, parents'
satisfactionwith the coursewas and still is assessed shortly after partic-
ipation. An analysis of these data revealed constantly high or increasing
ratings over the years [23]. Our study contributes to these encouraging
ﬁndings by showing that parents' ratings remain high even six months
later.
4.4. Limitations and strengths
Our evaluation of the FAMOSES parents' program is the ﬁrst study of
a psychoeducational program for families of CWE replicating the results
of a previous study [23,24]. This was possible because the FAMOSES
program has been regularly implemented in a number of German,
Austrian, and Swiss epilepsy centers for more than 10 years. The
encouragingly high number of study participants, especially in the
FAMOSES group, is due to this wide use of the program and increases
the generalizability of our results. “Train-the-trainer” courses and the
detailed trainer's manual further contribute to the external validity.
The lack of random assignment of participants to study groups is a
weakness of our study. This possible threat to validity is common in
studies evaluating psychosocial interventions for patients with epilepsy
or families of CWE [21,40,41]. It may lead to differences between the
groups so that effects are attributable to these differences rather than
to program participation. However, results from randomized studies
can be approached in quasi-experimental designs, given the correct
choice and control of covariates [43]. In our study, we did so by
matching FAMOSES and control group on important demographic and
disease-related variables. This and the inclusion of children's seizure
frequency in the analyses as a time-varying variable increased
the internal validity of our results. Furthermore, additional analyses
conﬁrmed the effects for speciﬁc subgroups.
The instruments used in this study were mainly speciﬁcally devel-
oped to cover the aims of the FAMOSES parents' program. To increase
comparability between studies, the use of standardized outcome
measures is generally recommended [40], yet appropriate question-
naires are not available for most outcome epilepsy-speciﬁc criteria.
However, we were able to develop reliable instruments based on the
previous study. These instruments may be used in future studies, for
instance in evaluations of other educational programs or psychosocial
care.
The current study is limited to the evaluation of the FAMOSES
parents' program. Although the FAMOSES parents' and children's
programs have been developed at the same time and it is assumedthat the parallel participation of parents and children is advantageous
[23], the two programs are independent. Since parents can take part
in the parents' course even if their child is too young or too impaired
for the children's program, the target groups of both programs only
partly overlap. Future research should therefore aim at evaluating the
efﬁcacy of the FAMOSES children's program from both children's and
parents' perspective and the combination of children's and parents'
program.
5. Conclusion
This controlled multicenter study conﬁrmed the efﬁcacy of the
FAMOSES program for parents of CWE. The successful improvement of
knowledge about epilepsy and the interactive approach of the program
help parents to cope with their child's disorder and reduce epilepsy-
related fears. Together with the wide and regular implementation in
many epilepsy centers and participants' high satisfaction with the
course, this makes the FAMOSES parents' program a valuable compo-
nent of comprehensive epilepsy care.
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